Advertisement
Canada markets closed

  • S&P/TSX

    22,259.47
    +312.06 (+1.42%)
     

  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     

  • DOW

    38,852.27
    +176.59 (+0.46%)
     

  • CAD/USD

    0.7320
    -0.0002 (-0.02%)
     

  • CRUDE OIL

    78.90
    +0.42 (+0.54%)
     

  • Bitcoin CAD

    86,774.34
    -1,018.45 (-1.16%)
     

  • CMC Crypto 200

    1,368.37
    +55.74 (+4.25%)
     

  • GOLD FUTURES

    2,337.50
    +6.30 (+0.27%)
     

  • RUSSELL 2000

    2,060.67
    +24.95 (+1.23%)
     

  • 10-Yr Bond

    4.4890
    -0.0110 (-0.24%)
     

  • NASDAQ futures

    18,179.00
    -16.50 (-0.09%)
     

  • VOLATILITY

    13.49
    0.00 (0.00%)
     

  • FTSE

    8,213.49
    +41.34 (+0.51%)
     

  • NIKKEI 225

    38,659.28
    +423.21 (+1.11%)
     

  • CAD/EUR

    0.6790
    -0.0002 (-0.03%)
     

Stocks in play: Crescita Therapeutics Inc.

Baystreet.ca

Reported its financial results for the second quarter ended June 30, 2023. Revenue was $5.1 million, compared to $6.5 million down $1.350 million; Gross profit was just over $3 million compared to $3.647 million, down $578,000. Operating expenses were $3.295 million, compared to $3.447 million, down $152,000. Adjusted EBITDA was $214,000 compared to $646,000, down $432,000. Ending cash was $10,226, down $49 for the quarter. Crescita Therapeutics Inc. shares T.CTX are trading down $0.03 at $0.70.

Read: